DelistingJul 23, 2026, 05:01 PM
InspireMD Receives Nasdaq Delisting Notice for Bid Price
AI Summary
InspireMD, Inc. received a notice from Nasdaq on July 17, 2026, indicating non-compliance with the minimum bid price requirement for continued listing. The company's common stock traded below $1.00 for 30 consecutive business days. InspireMD has been granted a 180-calendar-day period, until January 13, 2027, to regain compliance by maintaining a closing bid price of at least $1.00 for ten consecutive business days. The company is evaluating options, including a reverse stock split, to address the deficiency.
Key Highlights
- InspireMD received a Nasdaq notice on July 17, 2026, for non-compliance with the minimum bid price rule.
- The company's common stock bid price was below $1.00 for 30 consecutive business days (June 3 - July 16, 2026).
- InspireMD has 180 calendar days, until January 13, 2027, to regain compliance.
- To regain compliance, the closing bid price must be at least $1.00 for ten consecutive business days.
- The company may be eligible for an additional 180-day compliance period under certain conditions.
- InspireMD plans to monitor its stock price and consider options, including a reverse stock split.
Price Impact
More from NSPR